Ultralife Corp. (NASDAQ:ULBI) Short Interest Update

Ultralife Corp. (NASDAQ:ULBI) was the recipient of a significant growth in short interest in the month of June. As of June 30th, there was short interest totalling 102,300 shares, a growth of 24.2% from the May 30th total of 82,400 shares. Currently, 1.2% of the shares of the company are short sold. Based on an average daily trading volume, of 48,100 shares, the days-to-cover ratio is presently 2.1 days.

Several hedge funds and other institutional investors have recently bought and sold shares of ULBI. Dimensional Fund Advisors LP increased its holdings in shares of Ultralife by 1.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,060,836 shares of the technology company’s stock worth $7,161,000 after purchasing an additional 10,628 shares during the period. Barclays PLC increased its stake in Ultralife by 153.5% in the fourth quarter. Barclays PLC now owns 11,433 shares of the technology company’s stock valued at $77,000 after acquiring an additional 6,923 shares during the last quarter. Tibra Equities Europe Ltd bought a new position in Ultralife in the first quarter valued at approximately $317,000. Teton Advisors Inc. increased its stake in Ultralife by 37.1% in the first quarter. Teton Advisors Inc. now owns 81,300 shares of the technology company’s stock valued at $835,000 after acquiring an additional 22,000 shares during the last quarter. Finally, O Shaughnessy Asset Management LLC increased its stake in Ultralife by 48.5% in the first quarter. O Shaughnessy Asset Management LLC now owns 17,036 shares of the technology company’s stock valued at $175,000 after acquiring an additional 5,567 shares during the last quarter. 32.86% of the stock is currently owned by hedge funds and other institutional investors.

Shares of NASDAQ ULBI traded down $0.07 during trading on Friday, hitting $8.02. The company had a trading volume of 16,871 shares, compared to its average volume of 35,581. The company has a 50 day simple moving average of $7.99. Ultralife has a 12 month low of $6.30 and a 12 month high of $11.97. The company has a market capitalization of $126.23 million, a price-to-earnings ratio of 5.61 and a beta of 0.88.

Ultralife (NASDAQ:ULBI) last posted its quarterly earnings data on Thursday, May 2nd. The technology company reported $0.03 EPS for the quarter. Ultralife had a return on equity of 24.56% and a net margin of 27.96%. The firm had revenue of $18.88 million for the quarter.

About Ultralife

Ultralife Corporation designs, manufactures, installs, and maintains power, and communication and electronic systems for government, defense, and commercial sectors worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium ion cells, multi-kilowatt module lithium ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.

Read More: What is a stock buyback?

Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.